These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 31838206)
1. Stimuli-responsive polymeric prodrug-based nanomedicine delivering nifuroxazide and doxorubicin against primary breast cancer and pulmonary metastasis. Luo L; Xu F; Peng H; Luo Y; Tian X; Battaglia G; Zhang H; Gong Q; Gu Z; Luo K J Control Release; 2020 Feb; 318():124-135. PubMed ID: 31838206 [TBL] [Abstract][Full Text] [Related]
2. Enzyme/pH dual stimuli-responsive nanoplatform co-deliver disulfiram and doxorubicin for effective treatment of breast cancer lung metastasis. Xiao P; Tao X; Wang H; Liu H; Feng Y; Zhu Y; Jiang Z; Yin T; Zhang Y; He H; Gou J; Tang X Expert Opin Drug Deliv; 2023; 20(7):1015-1031. PubMed ID: 37452715 [TBL] [Abstract][Full Text] [Related]
3. Codelivered Chemotherapeutic Doxorubicin Lan Y; Liang Q; Sun Y; Cao A; Liu L; Yu S; Zhou L; Liu J; Zhu R; Liu Y ACS Appl Mater Interfaces; 2020 Jul; 12(28):31904-31921. PubMed ID: 32551517 [TBL] [Abstract][Full Text] [Related]
4. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy. Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147 [TBL] [Abstract][Full Text] [Related]
5. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy. Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753 [TBL] [Abstract][Full Text] [Related]
6. pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy. Ma B; Zhuang W; Wang Y; Luo R; Wang Y Acta Biomater; 2018 Apr; 70():186-196. PubMed ID: 29452272 [TBL] [Abstract][Full Text] [Related]
7. Smart Chondroitin Sulfate Micelles for Effective Targeted Delivery of Doxorubicin Against Breast Cancer Metastasis. Yu J; Xie X; Wang L; Liu W; Xu H; Lu X; Li X; Ren J; Li W Int J Nanomedicine; 2023; 18():663-677. PubMed ID: 36798532 [TBL] [Abstract][Full Text] [Related]
8. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine. Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129 [TBL] [Abstract][Full Text] [Related]
9. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition. Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294 [TBL] [Abstract][Full Text] [Related]
10. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis. Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin delivered by redox-responsive Hyaluronic Acid-Ibuprofen prodrug micelles for treatment of metastatic breast cancer. Chai Z; Teng C; Yang L; Ren L; Yuan Z; Xu S; Cheng M; Wang Y; Yan Z; Qin C; Han X; Yin L Carbohydr Polym; 2020 Oct; 245():116527. PubMed ID: 32718631 [TBL] [Abstract][Full Text] [Related]
12. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug. Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928 [TBL] [Abstract][Full Text] [Related]
13. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy. Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743 [TBL] [Abstract][Full Text] [Related]
14. Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy. Yang Y; Pan D; Luo K; Li L; Gu Z Biomaterials; 2013 Nov; 34(33):8430-43. PubMed ID: 23896006 [TBL] [Abstract][Full Text] [Related]
15. Synergistically Enhanced Antimetastasis Effects by Honokiol-Loaded pH-Sensitive Polymer-Doxorubicin Conjugate Micelles. Zou Y; Zhou Y; Jin Y; He C; Deng Y; Han S; Zhou C; Li X; Zhou Y; Liu Y ACS Appl Mater Interfaces; 2018 Jun; 10(22):18585-18600. PubMed ID: 29749228 [TBL] [Abstract][Full Text] [Related]
16. Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model. Yang F; Hu M; Lei Q; Xia Y; Zhu Y; Song X; Li Y; Jie H; Liu C; Xiong Y; Zuo Z; Zeng A; Li Y; Yu L; Shen G; Wang D; Xie Y; Ye T; Wei Y Cell Death Dis; 2015 Mar; 6(3):e1701. PubMed ID: 25811798 [TBL] [Abstract][Full Text] [Related]
17. Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug. Chen K; Cai H; Zhang H; Zhu H; Gu Z; Gong Q; Luo K Acta Biomater; 2019 Jan; 84():339-355. PubMed ID: 30503561 [TBL] [Abstract][Full Text] [Related]
18. Cargo-Free Nanomedicine with pH Sensitivity for Codelivery of DOX Conjugated Prodrug with SN38 To Synergistically Eradicate Breast Cancer Stem Cells. Sun N; Zhao C; Cheng R; Liu Z; Li X; Lu A; Tian Z; Yang Z Mol Pharm; 2018 Aug; 15(8):3343-3355. PubMed ID: 29923726 [TBL] [Abstract][Full Text] [Related]
19. Acid-sensitive lipidated doxorubicin prodrug entrapped in nanoemulsion impairs lung tumor metastasis in a breast cancer model. Dos Santos Câmara AL; Nagel G; Tschiche HR; Cardador CM; Muehlmann LA; de Oliveira DM; Alvim PQ; Azevedo RB; Calderón M; Figueiró Longo JP Nanomedicine (Lond); 2017 Aug; 12(15):1751-1765. PubMed ID: 28703043 [TBL] [Abstract][Full Text] [Related]
20. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis. Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]